'WHO's recommendation against Ivermectin is shrouded in suspicion' - Andrew Bannister

Loading player...
Andrew Bannister’s article ‘Don’t mention Ivermectin; it’ll upset the vaccine rollout’ was published on BizNews.com in May. The article gained an extensive amount of traction, which isn’t all that surprising considering mainstream media’s lack of coverage on alternative Covid-19 treatment. Bannister, a photographer and hotelier by trade, wrote a follow-up article titled ‘Conflict of Interest in WHO Recommendation Against Ivermectin’ which takes a deep dive into the sordid nature of the ‘financial and ideological conflicts of interest that have blocked the usage of this life-saving medication.’ BizNews spoke to Bannister about the various conflicts of interest which he outlines in his article as well as the various studies which have been released - both advocating for and against the use of Ivermectin as treatment for Covid-19. Bannister states that the World Health Organisation needs to ‘prove that it followed a scientific and ethical process in its recommendation against the use of ivermectin’ and that without the minutes of the meeting in which the organisation made its recommendation on ivermectin ‘the recommendation against the use of ivermectin remains mired in suspicion of corporate overreach.’ As global citizens all facing the same unprecedented crisis, surely - at the very least - we have a right to information which may assist us in making the best decisions possible for our health. Learn more about your ad choices. Visit megaphone.fm/adchoices
13 Jul 2021 7AM English South Africa Investing · Business News

Other recent episodes

BN Daybreak: SA-Israel tension; Nvidia-OpenAI deal; US tariffs; Fed rate outlook; Energy Risks

In today's BizNews Daybreak, we explore global market pressures, starting with new US Section 301 tariffs affecting South Africa and 60 other economies. Former Israeli adviser Mark Regev discusses strained Pretoria-Israel relations and ICJ genocide charges. Furthermore, we preview upcoming central bank rate decisions, Nvidia’s potential $250B OpenAI data center…
26 Jul 11PM 14 min

Boardroom Talk: RIP RW Johnson - leaving a huge hole in your nation's heart

In today's Boardroom Talk, Alec Hogg confirms the death of RW Johnson, one of South African political writing's sharpest and most combustible voices, and reflects on a decade of working with him: the audiobook that started it, the necrotising fasciitis he refused to let slow him down, the Steenhuisen column…
22 Jul 5AM 19 min

Unlocking High-Yield Private Debt: The Jaltech Income Opportunities Fund

Join the leadership team at Jaltech for an exclusive overview of the new Jaltech Income Opportunities Fund - a spin-off from their highly successful Section 12J investment strategy. Designed to target structured debt funding for established, mid-sized South African businesses, this fund addresses an unserved niche left open by traditional…
24 Jul 5AM 29 min